0 items USD 0.00Search
Your search for "delveinsight diabetic peripheral neuropathy pipeline insights 2015" gave back 1019017 results.
The global Chemotherapy Induced Peripheral Neuropathy Treatment market size was valued at USD 1723.6 million in 2023 and is forecast to a readjusted...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Drugs In Development, 2021 Summary Placenta Growth Factor (...
Catalog:
Global Markets Direct
August 2021
Price: USD 3,500.00
Vascular Endothelial Growth Factor B - Pipeline Review, H1 2020 Summary Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) -...
Catalog:
Global Markets Direct
January 2020
Price: USD 3,500.00
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2018 Summary According to the recently...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Placenta Growth Factor - Pipeline Review, H2 2020 Summary According to the recently published report 'Placenta Growth Factor - Pipeline Review,...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
The global Chemotherapy Induced Peripheral Neuropathy Treatment market size was valued at US$ 1638.7 million in 2023. With growing demand in...
Catalog:
LPI
January 2024
Price: USD 3,660.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
MRRPB5
January 2023
Price: USD 4,000.00
Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is...
Catalog:
GIR
January 2023
Price: USD 3,480.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
Nuclear Factor Erythroid 2 Related Factor 2 - Pipeline Review, H1 2020 Summary Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Placenta Growth Factor - Pipeline Review, H1 2020 Summary Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) pipeline...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
Placenta Growth Factor - Pipeline Review, H2 2019 Summary Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) pipeline...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The report...
Catalog:
IQ4I
December 2018
Price: USD 3,600.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
GIR
January 2023
Price: USD 3,480.00
